Surrogacy News

  • ALL
  • Surrogacy techniques
  • Company News
  • Surrogacy Industry News
    • The optimal range for egg retrieval in IVF: 8–15 eggs yield the highest live birth rate

    The optimal range for egg retrieval in IVF: 8–15 eggs yield the highest live birth rate

    2025-07-14

    When 38-year-old Emma learned that her first round of ovarian stimulation yielded only six eggs, she was nearly devastated. However, her reproductive specialist, Jennifer Lee, presented her with a data report: “Among these six eggs, three are rated as high-quality—this potential surpasses that of 20 average-quality eggs.”  In the field of IVF, a deeply ingrained misconception has persisted for years: the more eggs retrieved, the higher the success rate. However, a multi-center study published in 2025 in *Frontiers in Reproductive Medicine* revealed that the optimal range for IVF egg retrieval is 8–15 eggs, which represents the peak live birth rate. Retrieving more than 20 eggs actually reduces the live birth rate by 12%¹¹⁰. This finding completely overturns the traditional belief that “more is better.” I. Quantity ≠ Success Rate: The Critical Role of Egg Quality The harsh reality of clinical data 8–15 egg group: Cumulative live birth rate reaches 68% (Harvard Fertility Center 2024 data) >20 egg group: Live birth rate drops to 56%, and the risk of ovarian hyperstimulation syndrome (OHSS) increases threefold The single-egg miracle: Even with just one egg, if it is of high quality, there is still a 30%-45% chance of successful pregnancy Key mechanism: Excessive stimulation leads to estrogen levels exceeding physiological peaks, causing an increase in chromosomal abnormalities in oocytes and an elevated risk of embryonic aneuploidy. Dr. Michael Chen of the California Fertility Center notes: “Egg quality is the ultimate determinant of embryo potential—the value of a single MII-stage mature egg far exceeds that of 10 GV-stage immature eggs.” II. The scientific logic behind the optimal range: Why 8–15 is the best solution 1. The delicate balance between live birth rate and risk number of eggs retrieved live birth rate OHSS risk High-quality embryo rate ＜8 pieces 51% low 35% 8-15pieces 68% controllable…

    The truth about advanced fertility: waiting 1 year over 38 = scrapping 3 embryos!

    2025-07-09

    When 39-year-old Sarah stood tangled in the scale, Dr. Wilson of Harvard Reproductive Center handed her a data report:  “It takes six months to lose 20 pounds, but your ovarian reserve has plummeted by 40% – that’s enough six months to drop the live birth rate from 32% to 18%! ”  I. The global top journal overturns the perception: age is the ultimate judge of fertility A five-center, 115,000-case study in China (2023) Age grouping Decline in cumulative live birth rate Equivalent embryo loss 35-37岁 ↓46% Loss of 4 blastocysts 38-40岁 ↓68% Loss of 8 blastocysts 41-42岁 ↓89% Loss of 15 blastocysts ≥43岁 ↓96% approach zero (math.) Striking finding: when age interference was excluded, BMI itself had no significant effect on live birth rate! The only clear risk of obesity is an increased probability of macrosomia (OR=1.24) Dr. Emily Park, director of the Yale Reproductive Center, notes that “a 0.2 ng/ml drop in AMH per month in women after the age of 38, and six months of waiting to lose weight is equivalent to actively destroying 3 usable embryos” II.the brutal age divider of weight loss benefits A cross-national study of 14,213 cases reveals the “economics of reproductive time”. 1. the opportunity cost of 1 year of weight loss (a person’s) age BMI downgrading effect Net gain in live birth rate ≤35years old Obesity → overweight +9% 36-38years old Must be obese → normal +5% ≥38 years old Any weight loss -12%～-24% 2. Feasibility of short-term weight loss sprints Age 33: 2.7kg loss in 3 months (BMI reduction of 1) can improve pregnancy rate  Age 37: 8.1kg loss in 3 months (BMI reduction of 3) is needed to be effective  Age 39+: 13.5kg loss in 3 months (BMI reduction of 5) – hardly clinically feasible III.The way to solve the…

    Why do fertility doctors always advise you to do IVF before it’s too late?

    2025-07-04

    When Sarah, 38, walked into the office, her AMH had dropped to 0.4ng/mL.  Dr. James Wilson of the New York Fertility Center pointed to her ovarian reserve curve and sighed, “If you had acted two years earlier, your live birth rate could have been three times higher.” I. Countdown to Fertility: The Cliff Drop in Ovarian Reserve A woman’s fertility potential is like an accelerating falling star – it loses 12% per year after the age of 30, and the rate of decline soars after the age of 35. The grim data reveals: 25-30 years old: 55%-60% IVF success rate, average number of eggs acquired 15-20  35 years old: success rate plummets to 45%, rate of chromosomally abnormal embryos reaches 40%  40 years old: live birth rate is only 20%-30%, risk of miscarriage exceeds 50%  45 years old and above: natural pregnancy rate approaches zero, need to rely on egg-supply programs  The truth about ovarian stockpiles is even more alarming: female babies are born carrying 2 million The truth about ovarian stock is even more alarming: baby girls are born with 2 million oocytes, with only 400,000 left at puberty. With a natural loss of 1,000 oocytes per month, less than 10% of the ovarian stock exists after the age of 35. A Spanish multicenter study confirms that the risk of implantation failure increases by 4.2% per year after the age of 40 (RR=1.042), even when embryos from younger donors are used, and that aging of the uterine microenvironment has become an independent risk factor. II .The cost of delay: how time eats away at fertility opportunities The vicious cycle of disease progression Endometriosis: a delay of 5 years can result in a 2-fold increase in the depth of infiltration of the lesion and a 30% decrease in pro-ovulatory responsiveness …

    ummer IVF success rates skyrocket 200%!

    Summer IVF success rates skyrocket 200%!

    2025-07-03

    As Emily lay on the transplant table for the seventh time, the full Boston summer sun was piercing the clinic’s shutters. The attending physician, Robert Harrison, smiled as he handed over the checklist, “Your transfer day falls on June  – we call summer the prime season for embryo implantation – and this time the numbers were optimized by 63% over the last time.” I. Surprising findings from the climate lab: how temperature rewrites in vitro outcomes 1. A clinical revolution at 25°N The Center for Reproductive Medicine followed 1,179 fresh cycles and found: Clinical pregnancy rates jumped 202% in the summer transplant group compared to the winter (long protocol patients)  The optimal temperature range was locked at 26.13-29.68°C, beyond which the gain effect disappeared  The effect was only significant in the long protocol, with no seasonal difference in the antagonist protocols 2. Global data confirms the “summer advantage”. Ten years of data from Affiliated Hospital of Zhengzhou University (sample size 24,420 cycles):  ✅ 61.24% live births in summer (57.70% in winter)  ✅ 0.5% increase in live births for every 1°C increase in temperature  Study by Boston Fertility Center, Harvard Medical School:  Clinical pregnancy rates for those who had their eggs retrieved in June were significantly higher than those in other months  Temperature is positively correlated with the rate of embryo implantation (p=0.02 for the test of trend) Dr. Linda Yang, Director of Reproductive Endocrinology at Yale University, states, “The fertility advantage of summer is essentially a synergistic evolution of organisms with their environment – just as migratory birds choose to breed in the spring, so human germ cells respond to photoperiod and temperature. “ II.Decoding the miracle of summer: five biological mechanisms revealed 1. Vitamin D: A Natural Embryonic Fertility Aid Ample summer sunshine raises serum vitamin D concentration by…

    IVF

    Farewell to the era of “blind selection”! Six Non-Invasive Techniques to Accurately Screen “Champion Embryos” for IVF

    2025-06-30

    In the field of assisted reproduction, a quiet revolution is revolutionizing the rules of IVF. Traditional embryo screening relies on visual observation by embryologists and invasive biopsies, which are not only subjective, but can also damage precious embryos. Nowadays, non-invasive embryo screening technology can accurately assess the developmental potential of embryos without touching them by analyzing trace biomarkers in the embryo culture fluid, pushing the IVF success rate to a new high. I. AI-enabled “Time Detective”: Embryo Development Tracking System Embryo evaluation has evolved from static “face painting” to dynamic “life documentary”. Time-lapse imaging + AI algorithm: The time-lapse imaging system records the embryo’s developmental trajectory every 10 minutes, while the AI algorithm analyzes 35 morphodynamic parameters such as the synchronization of cleavage and the speed of blastocyst expansion. Data from the University of Cambridge Reproduction Center showed that AI-assisted screening increased the identification rate of high-quality embryos to 89%, and the accuracy of live birth prediction reached 85%. 3D reconstruction breakthrough: The Stanford team developed a virtual 3D model of the embryo that can visualize the internal structure of the blastocyst, with an aneuploidy detection accuracy of 83%, effectively avoiding the risk of miscarriage caused by chromosomal abnormalities by more than 60%. Clinical effectiveness controversy: Although widely promoted in European reproduction centers, two multi-center RCTs showed that the difference in pregnancy rate did not reach a significant level compared to traditional morphology, and the investment in equipment was as high as $200,000, which restricts the popularization of the clinic. II.The non-invasive revolution of DNA: culture fluid free chromosome screening (NICS) When traditional biopsy faces the risk of chimerism misdiagnosis and embryo damage, NICS technology is becoming the new gold standard. Technological breakthrough: By capturing 5-10 pg/μL of free DNA in embryo culture fluid, 23 pairs of chromosomes are analyzed…

    Sperm quality warning men's health

    Sperm quality warning men’s health

    2025-06-24

    Introduction: When Fertility Becomes a Barometer of Health When Danish scientist Dr. Lærke Priskorn looked through 78,284 men’s records, a paradoxical pattern emerged: men with total motile sperm counts >120 million lived an average of 2.7 years longer than those with <5 million. The 50-year study revealed that the testes are not only the starting point of life, but also the silent sentinels of health and longevity – for every level of decline in semen quality, the risk of all-cause mortality climbs by 12%. I. The brutal truth beneath the cold data: the life codes of 80,000 men (i) The “dose-death effect” of semen parameters The Danish National Cohort Study (1965-2015) found a clear gradient association between semen quality and life expectancy: Semen parameters High-value group life expectancy Life expectancy in the low-value group poor life span Increase in risk of death Total motile sperm count 80.3 years 77.6 years 2.7 years +40% Sperm concentration (million/ml) 79.8 years 76.9 years 2.9 years +37% normal morphology rate 79.5 years 77.1 years 2.4 years +29% Dr. Niels Jørgensen, the study leader, emphasized that this association is independent of education level and underlying disease, suggesting that sperm quality is a “biological marker” of general health. (ii) The “survival paradox” of azoospermia Paradox: The risk of death in azoospermic individuals is lower than in those with very low sperm counts (77.8 vs. 77.6 years). Mechanism: Patients with obstructive azoospermia (vasectomy) have normal testicular function, whereas those with severe oligozoospermia often have systemic metabolic disturbances. Clinical warning: Men with sperm counts of 5-10 million/ml should be prioritized for screening of insulin resistance and thyroid function. II. Global crisis: warning of precipitous decline in sperm counts (i) Transcontinental trend of decline A meta-analysis by Hebrew University of Israel (223 studies/57,000 men) showed: 1973→2018: 51.6% decline in…

    35+ Women's Guide to Scientific Preparation for Pregnancy

    35+ Women’s Guide to Scientific Preparation for Pregnancy: Medical Strategies and Health Management for Fertility at Advanced Ages

    2025-06-21

    Introduction: When the Fertility Clock Meets Modern Medicine When Sophia Müller, a 39-year-old German engineer, saw the report of an AMH value of 0.8 ng/ml at the Berlin Fertility Center, the words of the head of the Fertility Department, Dr. James Wilson (Professor of Reproductive Medicine at the University of Oxford), renewed her hope: “Age is not an absolute barrier, and a scientific strategy can increase the rate of live births in women over 35 years of age to as much as 44 percent.” With the global surge in the proportion of first-time births at an advanced age (22% in the EU and 17.8% in China), a systematic program of scientific pregnancy preparation for 35+ women is becoming a focus of attention in the medical community. I. The 90 days before conception: the “foundation project” of fertility (i) Three steps of medical assessment Reproductive system in-depth screening  Ovarian reserve: AMH test (<1.1ng/ml suggests functional decline) + sinus follicle count (AFC <5 requires intervention)  Uterine environment: 3D ultrasound assessment of endothelial tolerance + hysteroscopy to exclude polyps/adhesions  Endocrine axis: sex hormone hexa-somes (with a focus on FSH>10IU/L, LH/FSH>2) Whole body metabolic function audit sports event threshold value Clinical intervention programs fasting blood sugar ＞5.1mmol/L Metformin + low carb diet TSH ＞2.5mIU/L Sodium levothyroxine replacement vitamin D ＜30ng/ml 5000 IU daily supplement Source: Shanghai First Maternity and Infant Hospital Metabolic Management Guidelines for Older Pregnancies Genetic Risk Screening  Karyotyping of couples (especially balanced translocation carriers)  Screening for carriers of single gene disorders (e.g., SMN1 gene for spinal muscular atrophy)  Recommendation of Dr. Emily Roberts, Harvard Center for Reproductive Genetics: mandatory CGG repeat sequence screening for couples ≥38 years of age (to prevent Fragile X syndrome) (ii) The “Golden Formula” for Nutritional Reserves Mitochondrial Activation Program  Coenzyme Q10 600mg/day → boosts egg ATP…

    Improving IVF Embryo Quality

    Strategies for Improving IVF Embryo Quality

    2025-06-20

    Introduction: When Biology Meets the Architect of Life When Elena Martínez, a 36-year-old Spanish teacher, experienced her third failed transfer, her fertility doctor, Dr. James Wilson (Harvard Fertility Center), presented a set of statistics that turned perceptions upside down: differences in the quality of in vitro embryos can result in a 3.2-fold difference in the live birth rate, and 60 percent of the loss of quality embryos stems from intervening factors.15 This revealed the central challenge of modern reproductive medicine – how to transform an embryo from a “mass of cells” into a “seed of life. This reveals the central challenge of modern reproductive medicine – how to transform an embryo from a “mass of cells” into a “seed of life”. This article analyzes the three dimensions of this strategy, incorporating evidence from top journals such as Human Reproduction. I. Biological microenvironmental remodeling: building the embryo’s “cell refinery”. (I) Nutritional Metabolic Engineering Optimization of mitochondrial fuel:  Coenzyme Q10: 600mg/day can increase ATP production by 40% and correct spindle assembly errors in women over 37 years old.  α-Lipoic acid: activate Nrf2 pathway, neutralize reactive oxygen species (ROS) in follicular fluid, and reduce embryo fragmentation by 35%. Methylation cycle regulation:  → active folic acid (5-MTHF) 2.5mg/day, corrects homocysteine abnormalities in MTHFR gene mutants  → Vitamin B12 1000μg synergizes to safeguard epigenetic reprogramming (ii) Oxidative stress defense system original proposal target of action Clinical benefits Applicable dosage for surrogate mothers selenium Glutathione peroxidase Reduced chromosome breakage rate by 28% 200μg/day vitamin E Membrane lipid peroxidation blockade Improved blastocyst formation rate 400IU/day Omega-3 Inflammatory factor IL-6 inhibition Enhancement of embryo implantation potential 1000mg DHA+ Data source: European Fertility Association Nutritional Guidelines 2025 Key finding: surrogate mothers who combine selenium + vitamin E supplementation have a 52% higher rate of blastocyst formation (compared to the…

    Scientific Selection Guide for Natural Fertilization vs IVF

    Scientific Selection Guide for Natural Fertilization vs IVF

    2025-06-17

    Introduction  Dear moms-to-be, as you embark on this extraordinary journey of fertility, natural conception and IVF are two very different routes. It is alarming that over 60% of mothers over 35 years of age go straight to IVF without evaluating the quality of their eggs, and end up in a war of attrition of “repeated ovulation – failed egg retrieval”. In this article, we will use data and clinical insights from top journals such as The Lancet to reveal the key to scientific decision-making. I. In vitro fertilization: a precise navigation system for modern reproductive medicine In vitro fertilization is not a “last resort”, but a targeted solution to overcome structural problems: Crossing physical barriers: In cases of tubal obstruction/endometriosis, IVF realizes sperm-egg binding in vitro. The New England Journal of Medicine confirms: surrogate mothers with tubal problems have a 45% pregnancy rate through IVF, a 9-fold increase over natural conception  Against Time Pressure: Mothers of expectant mothers over 38 years of age can achieve a 30% increase in the number of eggs they receive with a personalized ovulation regimen (Harvard Reproductive Center 2024 Clinical Report)  Dynamic Program Customization: Based on AMH values, sinus follicle counts, and other indicators, Dr. Emily Johnson (Stanford Reproductive Medicine) has been working on the development of an IVF program to address the structural challenges of the tubal problem. Dr. Emily Johnson (Director of Stanford Reproductive Medicine) recommends:  ✅ Microstimulation (low dose FSH)  ✅ Antagonist (early ovulation suppression)  ✅ PPOS (luteal phase ovulation stimulation)  Key Insight: IVF is a “fertility engine” for specific groups of mothers-to-be, but it is not a panacea! II.Egg quality: the core battleground for determining the success rate of expectant mothers. （Egg quality: the central battleground in determining surrogacy success rates (Comparison of data: Natural cycle vs.) physiological process​ natural cycle​…

    navigation menu

    tatecare

    Georgia Surrogacy Services,Legal IVF Hospital,Global Fertility Agency